Partnership Enhances Tinnitus Treatment Access
Neuromod Devices, a pioneer in tinnitus treatment, has recently teamed up with Treble Health to increase the availability of their cutting-edge bimodal neuromodulation device, Lenire, for patients suffering from tinnitus in Philadelphia and Charlotte. This collaboration brings together a distinguished hearing health service specializing in tinnitus treatment and a device that aims to reshape how tinnitus is managed.
What's New About Lenire?
Lenire is not just another hearing device; it uses a unique bimodal therapy approach that combines auditory stimulation through headphones and mild electrical pulses delivered to the tongue using a proprietary Tonguetip device. Studies, including recent research published in the American Journal of Audiology, demonstrate that after 12 weeks of at-home treatment, about 81.8% of patients with moderate to severe tinnitus reported significant improvements.
Expanding Patient Access to Innovative Therapy
With the expansion into Treble Health's network, patients in Philadelphia and Charlotte will have more opportunities to access Lenire. This hybrid care model ensures that patients can receive both telehealth consultations and in-person treatment. Eric Timm, CEO of Neuromod USA Inc, emphasizes the importance of this partnership for enhancing awareness and access to innovative tinnitus treatments, stating, “I’m delighted this partnership with Treble Health will give people living with tinnitus broader access to treatment.”
Clinical Efficacy and Real-World Impact
The clinical success of Lenire has garnered interest from numerous audiologists, many of whom have begun integrating this device into their treatment offerings. Gail Brenner, AuD, a tinnitus specialist, shared her enthusiasm: “The Lenire device has been an outstanding addition to our tinnitus treatment options as clinicians.” The peer-reviewed evidence supporting Lenire's effectiveness continues to grow, marking it as a noteworthy option for tinnitus patients.
What Does This Mean for Tinnitus Management?
The demand for effective tinnitus management solutions is on the rise, with approximately 25 million Americans affected by the condition, which often presents as a persistent ringing in the ears. Neuromod's expansion into new clinics follows their FDA De Novo approval, which sets the stage for wider access to treatment. As Dr. Erin Walborn, an audiologist, states, “As clinicians, expanding the care we provide to patients within our practice is something we take seriously.”
Looking Forward: Tinnitus Treatment in the Future
As Neuromod and Treble Health expand their services, patients can expect not only greater access to Lenire but also to a more interconnected healthcare experience. This partnership could signal a new era in the treatment of tinnitus, placing innovative devices like Lenire into the hands of trained professionals across more locations, allowing for an advanced approach to hearing health.
For those interested in exploring their options for tinnitus treatment, including seeing if Lenire is right for them, further information can be found by visiting this link or calling (860) 663-6517 for assistance.
Add Row
Add
Write A Comment